JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...

JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price ...

JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

The killing U.S. bettors made this NFL season could nudge legal sports betting on this year’s Super Bowl toward $2 billion in regulated action.

Even with its well-documented benefits, DoE is often underutilised, especially for solving specialised or constrained ...

AI is evolving rapidly with recent breakthroughs making it more accessible and efficient than ever. Smaller, cost-effective ...

We recently compiled a list of the 12 AI News Investors Probably Missed. In this article, we are going to take a look at ...

We recently compiled a list of the 10 AI Stocks to Watch Amid the DeepSeek Buzz. In this article, we are going to take a look ...

The web services and cybersecurity specialist's share price ended the day's trading up 10.7% amid the backdrop of a 0.8% gain ...

CrowdStrike Holdings was recently the Nasdaq's best-performing stock as it and other cybersecurity companies got a boost after Chinese artificial intelligence startup DeepSeek reported a cyberattack.